Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
Wenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110210-110210
Open Access | Times Cited: 122

Showing 26-50 of 122 citing articles:

Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike
Timothy J.C. Tan, Abhishek Kumar Verma, Abby Odle, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Open Access | Times Cited: 8
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses
Peter Halfmann, Steven J. Frey, Kathryn Loeffler, et al.
EBioMedicine (2022) Vol. 86, pp. 104341-104341
Open Access | Times Cited: 36
Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
Qingrui Huang, Xiaonan Han, Jinghua Yan
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2412-2422
Open Access | Times Cited: 30
The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice
Irfan Ullah, Guillaume Beaudoin-Bussières, Kelly Symmes, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100893-100893
Open Access | Times Cited: 29
Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
Wan-Ling Wu, Chen-Yi Chiang, Szu-Chia Lai, et al.
JCI Insight (2022) Vol. 7, Iss. 8
Open Access | Times Cited: 27
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 11
Open Access | Times Cited: 27
Broadly neutralizing antibodies against COVID-19
Daming Zhou, Jingshan Ren, Elizabeth E. Fry, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101332-101332
Open Access | Times Cited: 19
Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans
David Chmielewski, Eric Wilson, Grigore Pintilie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
Tetsuya Inoue, Yuichiro Yamamoto, Kaoru Sato, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109363-109363
Open Access | Times Cited: 5
T‐Cell‐Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS‐CoV‐2 Infection
Wenyan Fu, Wei Zhang, Zuhui You, et al.
Advanced Science (2025)
Open Access
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon
Mehdi Benlarbi, Dell-Dylan Kenfack, Katrina Dionne, et al.
Virology (2025) Vol. 605, pp. 110467-110467
Closed Access
Unveiling the Complete Spectrum of SARS-CoV-2 Fusion Stages by In Situ Cryo-ET
Caner Akıl, Jialu Xu, Juan Shen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes
Masaud Shah, Sung Ung Moon, Ji‐Yon Shin, et al.
Advanced Science (2025)
Open Access
Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2
Meng Yuan, Yiquan Wang, Huibin Lv, et al.
Cell Reports (2022) Vol. 41, Iss. 7, pp. 111650-111650
Open Access | Times Cited: 24
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
Wei Shi, Lingshu Wang, Tongqing Zhou, et al.
Structure (2022) Vol. 30, Iss. 9, pp. 1233-1244.e7
Open Access | Times Cited: 22
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Alexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111554-111554
Open Access | Times Cited: 22
Emerging anti-spike monoclonal antibodies against SARS-CoV-2
Eloy E. Ordaya, Raymund R. Razonable
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 191-201
Closed Access | Times Cited: 4
Current Status and Perspectives of Therapeutic Antibodies Targeting the Spike Protein S2 Subunit against SARS-CoV-2
Yuichiro Yamamoto, Tetsuya Inoue
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 5, pp. 917-923
Open Access | Times Cited: 4
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease
Pan-Pan Zhou, Ge Song, Wanting He, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 21
Inducing broad-based immunity against viruses with pandemic potential
Alessandro Sette, Erica Ollmann Saphire
Immunity (2022) Vol. 55, Iss. 5, pp. 738-748
Open Access | Times Cited: 21
Antibody-mediated immunity to SARS-CoV-2 spike
John M. Errico, Lucas J. Adams, Daved H. Fremont
Advances in immunology (2022), pp. 1-69
Open Access | Times Cited: 20
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
Payton A. Weidenbacher, Eric Waltari, Izumi de los Rios Kobara, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 11, pp. 1270-1276
Open Access | Times Cited: 20
HIV-1 Vpu restricts Fc-mediated effector functions in vivo
Jérémie Prévost, Sai Priya Anand, Jyothi Krishnaswamy Rajashekar, et al.
Cell Reports (2022) Vol. 41, Iss. 6, pp. 111624-111624
Open Access | Times Cited: 19
State of the Art in Epitope Mapping and Opportunities in COVID-19
Samira M. Hamed, Masarra M. Sakr, Ghadir S. El-Housseiny, et al.
Future Science OA (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11

Scroll to top